Active substanceVaccine for the prevention of meningococcal infectionsVaccine for the prevention of meningococcal infections Similar drugsTo uncover Vaccine meningococcal group A polysaccharide dry lyophilizate PC MICROGEN FGUP Scientific and Production Association Russia MENACTRA solution w / m Sanofi Pasteur S.A. France Mentsevax® ACWY lyophilizate PC GlaxoSmithKline Trading, ZAO Russia Menugate lyophilizate w / m GlaxoSmithKline Trading, ZAO Russia Polysaccharide meningococcal vaccine A + C lyophilizate w / m PC Sanofi Pasteur S.A. France Dosage form: & nbsplyophilizate for the preparation of a suspension for intramuscular and subcutaneous administration Pharmacotherapeutic group:MIBP vaccine ATX: & nbspJ.07.A Vaccines for the prevention of bacterial infectionsJ.07.A.H Vaccine for the prevention of meningitis Form release / dosage:Lyophilizate for the preparation of a suspension for intramuscular and subcutaneous administration, 0.5 ml / dose. Packaging:(1) - vials (1) / complete with solvent (syringes) 0.5 ml / - packings(10) - bottles (10) / complete with a solvent (bottles) 5 ml-10 pcs. (in a separate box) / - carton boxes Shelf life:3 years. Terms of leave from pharmacies:On prescription Registration number:П N010110 Date of registration:17.06.2008 The owner of the registration certificate:Sanofi Pasteur S.A.Sanofi Pasteur S.A. France Manufacturer: & nbspSANOFI PASTEUR, S.A. France Representation: & nbspSanofi Pasteur S.A.Sanofi Pasteur S.A. Information update date: & nbsp16.12.2015 Illustrated instructions × Illustrated instructions Instructions